Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase).
- DOI
- 10.1093/hropen/hoae072
- Published
- 2025
- Container
- Human reproduction open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/hropen/hoae072,
title = {Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase).},
author = {Henry A and Santulli P and Bourdon M and Maignien C and Chapron C and Treluyer JM and Guibourdenche J and Chouchana L},
year = {2025},
journal = {Human reproduction open},
doi = {10.1093/hropen/hoae072},
url = {https://doi.org/10.1093/hropen/hoae072}
}RIS
TY - JOUR TI - Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase). AU - Henry A AU - Santulli P AU - Bourdon M AU - Maignien C AU - Chapron C AU - Treluyer JM AU - Guibourdenche J AU - Chouchana L PY - 2025 JO - Human reproduction open DO - 10.1093/hropen/hoae072 UR - https://doi.org/10.1093/hropen/hoae072 ER -
APA
A, H., P, S., M, B., C, M., C, C., JM, T., J, G., & L, C. (2025). Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase).. Human reproduction open. https://doi.org/10.1093/hropen/hoae072
Source records
- pubmed · retrieved 2026-09-27T15:55:56.876Z